Avidity Partners logo

Avidity Partners

North America, Texas, United States, Dallas

Description

Avidity Partners is an investment management firm that offers financial services.

Investor Profile

Avidity Partners has made 66 investments, with 9 in the past 12 months and 18% as lead.

Stage Focus

  • Post Ipo Equity (41%)
  • Series B (29%)
  • Series C (14%)
  • Series D (5%)
  • Series E (3%)
  • Series Unknown (3%)
  • Series A (3%)
  • Series F (3%)

Country Focus

  • United States (80%)
  • Canada (9%)
  • United Kingdom (6%)
  • China (3%)
  • Switzerland (2%)

Industry Focus

  • Biotechnology
  • Health Care
  • Medical
  • Pharmaceutical
  • Therapeutics
  • Biopharma
  • Medical Device
  • Health Diagnostics
  • Life Science
  • Wellness
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Avidity Partners frequently co-invest with?

EcoR1 Capital
North America, California, United States, San Francisco
Co-Investments: 9
OrbiMed
North America, New York, United States, New York
Co-Investments: 10
Surveyor Capital
North America, Illinois, United States, Chicago
Co-Investments: 13
Casdin Capital
North America, New York, United States, New York
Co-Investments: 9
RTW Investments
North America, New York, United States, New York
Co-Investments: 10
RA Capital Management
North America, Massachusetts, United States, Boston
Co-Investments: 14
Ally Bridge Group
Asia, Hong Kong Island, Hong Kong, Hong Kong
Co-Investments: 9
Perceptive Advisors
North America, New York, United States, New York
Co-Investments: 14
Redmile Group
North America, California, United States, San Francisco
Co-Investments: 9
Janus Henderson Investors
Europe, England, United Kingdom, London
Co-Investments: 15

Which angels does Avidity Partners often collaborate with?

SK
North America, California, United States, Los Angeles
Shared Deals: 1
Shared Deals: 1
JR
North America, California, United States, San Francisco
Shared Deals: 1
RK
North America, California, United States, Los Angeles
Shared Deals: 1
AK
North America, California, United States, Los Angeles
Shared Deals: 1

What are some of recent deals done by Avidity Partners?

OrganOx

Oxford, Oxfordshire, United Kingdom

OrganOx is a medical technology company.

Health CareMedicalMedical Device
Series UnknownFeb 24, 2025
Amount Raised: $142,000,000
Sirona Medical

San Francisco, California, United States

Sirona Medical transforms radiology with a cloud-native platform unifying worklist, viewer, reporter, archive, and AI into one workspace.

Artificial Intelligence (AI)Health CareSoftware
Series CNov 26, 2024
Amount Raised: $42,000,000
Aktis Oncology

Boston, Massachusetts, United States

Aktis Oncology is a biotechnology company that designs and develops novel class radiopharmaceuticals.

BiotechnologyHealth CareLife ScienceOncology
Series BSep 30, 2024
Amount Raised: $175,000,000
858 Therapeutics

San Diego, California, United States

858 Therapeutics develops small molecule drugs targeting oncology and immunology.

BiotechnologyHealth CarePharmaceutical
Series BSep 26, 2024
Amount Raised: $50,000,000
Helaina

New York, New York, United States

Helaina is a biotechnology company that focuses on advanced nutrition through the replication of functional proteins.

BiotechnologyHealth CareParentingPersonal Health
Series BSep 25, 2024
Amount Raised: $45,000,000
Oruka Therapeutics

Waltham, Massachusetts, United States

Oruka Therapeutics is advancing innovative biologics to redefine patient care standards in chronic skin diseases.

BiotechnologyHealth CareMedical
Post Ipo EquitySep 3, 2024
Amount Raised: $275,000,000
Context Therapeutics

Philadelphia, Pennsylvania, United States

Context Therapeutics is a clinical-stage biopharmaceutical company.

BiotechnologyHealth Care
Post Ipo EquityMay 2, 2024
Amount Raised: $100,000,000
Endeavor BioMedicines

Solana Beach, California, United States

Endeavor BioMedicines develops new treatments targeting the underlying causes of pulmonary fibrosis.

BiotechnologyHealth CareMedical
Series CApr 24, 2024
Amount Raised: $132,500,000
Cullinan Therapeutics

Cambridge, Massachusetts, United States

Cullinan Therapeutics is a developer of an externally sourced cancer therapeutics used to end a drug program quickly.

BiopharmaBiotechnologyMedical DeviceOncology
Post Ipo EquityApr 16, 2024
Amount Raised: $280,000,000
TORL BioTherapeutics

Culver City, California, United States

TORL BioTherapeutics is a clinical-stage biopharmaceutical business.

BiopharmaBiotechnologyClinical Trials
Series BApr 10, 2024
Amount Raised: $158,000,000